Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.


TSXV:RHT.H - Post by User

Post by theinvestor22on Mar 03, 2023 9:32am
308 Views
Post# 35317161

Fundamentals - Part 2

Fundamentals - Part 2On Feb 11th, I posted something on the company's price/revenue multiple to show how it was declining over a period of time, meaning that the stock price was becoming cheaper.  I thought it might be a good idea to update my posting now that fQ2 results have been issued.

First, the guts of my original posting...

(Note: for the following, I've used the price on the day of each earnings release, the revenue as supplied by the company in a couple of MD&As, annualized quarterly results and the basic share count.)
 
When Q1 f2021 results were announced, the price/revenue multiple was about $0.265 stock price / ($170k rev x 4 Qs / 143,119 sh) = 55.8
 
When Q1 f2022 results were announced, the price/revenue multiple was about $1.25 stock price / ($1,608k rev x 4 Qs / 176,634 sh) = 34.3
 
When Q1 f2023 results were announced, the price/revenue multiple was about $0.69 stock price / ($3,472k rev x 4 Qs / 189,356 sh) = 9.4
 
Since the price is currently $0.51, the current price/revenue multiple is about $0.51 stock price / ($3,472k rev x 4 Qs / 189,356 sh) = 7.0


Now, to add something for the latest results...

When Q2 f2023 results were announced, the price/revenue multiple was about $0.54 stock price / ($4,119k rev x 4 Qs / 195,759 sh) = 6.4

So, it seems the stock price is becoming even more reasonable.
<< Previous
Bullboard Posts
Next >>